Peter Thiel-backed psychedelic start-up's shares pop in Wall Street debut
June 18, 2021 at 14:30 PM EDT
The German biotech's initial public offering was priced Thursday night at $15 per share, the high end of the expected range.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|